A detailed history of Bryn Mawr Trust CO transactions in Haleon PLC stock. As of the latest transaction made, Bryn Mawr Trust CO holds 17,628 shares of HLN stock, worth $163,411. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,628
Previous 22,022 19.95%
Holding current value
$163,411
Previous $228,000 30.7%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 28, 2025

SELL
$8.72 - $10.35 $38,315 - $45,477
-4,394 Reduced 19.95%
17,628 $158,000
Q2 2025

Jul 28, 2025

SELL
$9.27 - $11.41 $25,409 - $31,274
-2,741 Reduced 11.07%
22,022 $228,000
Q1 2025

May 08, 2025

BUY
$9.02 - $10.67 $17,183 - $20,326
1,905 Added 8.33%
24,763 $254,000
Q4 2024

Jan 28, 2025

BUY
$9.23 - $10.71 $33,661 - $39,059
3,647 Added 18.98%
22,858 $218,000
Q3 2024

Nov 25, 2024

BUY
$8.32 - $10.7 $159,835 - $205,557
19,211 New
19,211 $203,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $42.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Bryn Mawr Trust CO Portfolio

Follow Bryn Mawr Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.